| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8419e94d26cc61ee3900f8f3156c7ef4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f802064db1ab14c51e462b1b55573ac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e48b64a660b04ef6ad4d80be096366e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b66b3487709fbd7cfc01a330c5cbb94e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02 |
| filingDate |
2006-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0189d40cfb14f8818687878903dc5d27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a17cefb5c24059b55e796e97585efe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae778eea33037a1e073469bdc78831e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2771a980128b6e98333b1ca5aec4b18 |
| publicationDate |
2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007032558-A1 |
| titleOfInvention |
Method of treating herpes viral infections using a halogenated hydrocarbon composition |
| abstract |
A method to reduce the incidence and time to healing of paraesthesia and skin lesions associated with herpes virus infections. In one form, the method of treatment involves topical application with an halogenated hydrocarbon alone, preferably ethyl chloride, which as a skin refrigerant, freezes the virus infected skin cells or subcutaneous skin cells. The desired result is a slowing or halting of the DNA replication cycle of the virus. Alternatively, the composition may be combined with an antiviral agent and compound to reduce pain and itching. The step of freezing the virus at the first signs of a skin lesion reduces the time to healing by allowing the body's own immune system a chance to attack the viral antigens thereby reducing the incidence and severity of skin lesions associated with herpes virus infections. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010298250-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609152-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8470378-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012164253-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014080776-A1 |
| priorityDate |
2004-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |